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ABSTRACT OF THESIS

THE ROLE OF STEM CELL ANTIGEN-1(Sca-1) IN MUSCLE AGING

Muscle aging is associated with a decrease in the number of satellite cells and their
progeny, muscle progenitor cells (MPCs) that are available for muscle repair and
regeneration. However, there is an increase in non-immuno-hematopoietic cells (CD45
negative) in regenerating muscle from aged mice characterized by high stem cell antigen
-1(Sca-1) expression. In aged regenerating muscle, 14.2% of cells are CD45neg Sca-1pos
while 7.2% of cells are CD45neg Sca-1pos in young adult muscle. In vitro, CD45neg Sca-1pos
cells over express genes associated with fibrosis, potentially controlled by Wnt2. These
cells are proliferative, non-myogenic and non-adipogenic, and arise in clonally-derived
MPCs cultures from aged mice. Both in vitro and in vivo studies suggest that CD45neg
Sca-1pos cells from aged muscle are more susceptible to apoptosis than their MPCs, which
may contribute to depletion of the satellite cell pool. Therefore, with age, a subset of
MPCs takes on an altered phenotype, which is marked by high Sca-1 expression. This
altered phenotype prevents these cells from participating in muscle regeneration or
replenishing the satellite cell pool, and instead may contribute to fibrosis in aged muscle.
KEYWORDS: Stem cell antigen-1, Hematopoietic Stem Cells, Skeletal muscle stem
cells, Muscle Aging, Fluorescent Activating Cell Sorting
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CHAPTER 1
Introduction
Stem Cells
There are approximately 10-100 trillion cells in an average human body. Stem
cells are rare cells, approximately 5 x 104 per tissue is found in all multi-cellular
organisms (Kindt 2007). These uniquely unspecialized cells are capable of self renewal
through mitotic cell division and give rise to a diverse range of differentiated and
specialized cell types that are needed to maintain tissue growth, homeostasis, and repair
throughout an organism’s life span (Till and Mc 1961). The two main types of
mammalian stem cells are: embryonic stem cells that are found in blastocysts and adult
stem cells that are found in adult tissues (Cheng 2008). Embryonic stem cells can
differentiate into all types of specialized embryonic tissues and are thus considered to be
totipotent. Pluripotent adult stem cells, identified in essentially all mammalian tissues,
can give rise to many differentiated cells types and have been hypothesized to have the
capacity to differentiate outside their tissue of origin (Krtolica 2005; Shizuru, Negrin et
al. 2005).

Adult stem cells reside in a variety of locations throughout the body and may
remain quiescent (non-dividing) for many years until they are activated by disease or
tissue injury (Weissman 2000; Kenyon and Gerson 2007). Upon activation, stem cells
can undergo either symmetric or asymmetric cell divisions (Fuller 2006; Holmes and
Stanford 2007). In symmetric cell division, either two new stem cells or two
differentiating cells are produced. In contrast, asymmetric cell division, results in one
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new stem cell, which either may return to quiescence or continue to divide, and a
progenitor cell, which is more restricted in differentiation potential, often referred to as
multipotent. Progenitor cells typically proliferate, and depending on environmental cues,
specialize into the appropriate differentiated cell type. Finally, stem cells may also
undergo apoptosis, resulting in depletion of the stem cell pool. Detailed studies involving
stem cells from bone marrow, peripheral blood, blood vessels, skeletal muscle, skin, and
liver have shown that upon manipulation in vitro, they can be induced to differentiate into
a number of different cell types (Weissman 2000; McKinney-Freeman 2002).
Regenerative medicine is based on the development of these techniques to control stem
cell fate so that they may be used to treat many serious diseases.

Hematopoietic Stem Cells
Hematopoietic stem cells (HSCs) are the best characterized adult stem cell population
(Wilson and Trumpp 2006; Huang, Cho et al. 2007). HSCs, which are derived from
whole bone marrow, have been shown to be capable of contributing to the regeneration of
skeletal muscle, cardiac muscle, liver, and multiple epithelial tissues (McKinney-Freeman
2002; Wong, Lowes et al. 2007). However, due to the rarity of HSCs, which account for
less than 0.5% of a mouse bone marrow cells, the identification and isolation of pure
populations of HSCs in sufficient numbers has been challenging (Spangrude, Heimfeld et
al. 1988; Harrison, Astle et al. 1989; Muller-Sieburg and Riblet 1996; Reya, Morrison et
al. 2001; Kamminga and de Haan 2006). For many years, HSC properties were inferred
from cell-based tissue repair assays (Montarras, Morgan et al. 2005; Shizuru, Negrin et
al. 2005). More recently, with the development of specific antibodies against cell surface
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antigens, researchers have been able to isolate and identify HSCs from both mouse and
human. Identification of unique markers on the surface of HSCs provided the basis for
the Fluorescence-Activated Cell Sorting (FACS) technique, by far the most effective and
most widely used method for identification and isolation of stem cells (Spangrude,
Heimfeld et al. 1988; Shizuru, Negrin et al. 2005; Wong, Lowes et al. 2007; Cheng
2008).

One of the markers whose expression defines HSCs in mice is stem cell antigen-1
(Sca-1). The Sca-1 gene is found on chromosome 15 and is a Ly-6A/E member of the Ly6 multigene family of glycosyl phosphatidylinositol (GPI)-anchored membrane proteins,
originally identified as an antigen upregulated on activated lymphocytes (Spangrude,
Aihara et al. 1988; Spangrude, Heimfeld et al. 1988; Miles, Sanchez et al. 1997;
Bradfute, Graubert et al. 2005; Holmes and Stanford 2007). It is regulated in a complex
fashion during hematopoietic cell differentiation. (A detailed discussion of the
progression of HSC restriction and differentiation is presented in Chapter 2 under Stem
Cell Hierarchy.) The expression of Sca-1 is down regulated (Akashi, Traver et al. 2000)
as HSCs differentiate into common myeloid progenitors (CMPs) which give rise to
monocytes

and

macrophages,

neutrophils,

basophils

eosinophils,

erythrocytes,

megakarocytes. As HSCs commit to the lymphoid progenitors, which give rise to T, B,
and natural killer (NK) cells, Sca-1 expression is decreased (Kondo, Weissman et al.
1997; Ito, Li et al. 2003). Sca-1 expression is turned off at an early stage of thymocyte
differentiation, and then re-expressed on mature single-positive medullary thymocytes
and peripheral T cells (Bamezai 2004). The expression is further upregulated in activated
lymphocytes (van de Rijn, Heimfeld et al. 1989). Expression of Sca-1 occurs outside the
3

hematopoietic system in the form of stem, progenitor and differentiated cell types in a
wide variety of tissues and organs, which makes it ideal for routine use in combination
with negative selection against mature markers for enrichment of stem and progenitor
cells (Bamezai 2004; Holmes and Stanford 2007). The in vivo functions of Sca-1 are
unknown, however, in vitro studies suggest that it plays a key role in cellular activation
(Gumley, McKenzie et al. 1995).

CD45, also known as the common leukocyte antigen, (T220 and B220 in mice) is
a protein tyrosine phosphatase located in all hematopoietic cells except erythrocytes and
platelets (Thomas 1989; Barford, Flint et al. 1994; Goodell, Brose et al. 1996; Gussoni,
Soneoka et al. 1999). This protein has several isoforms and HSCs express one or more of
these isoforms at specific stages of differentiation. CD45 is uniformly distributed in
plasma membrane, constituting 10% of the cell surface protein of T cell and B cells, and
facilitates signal transduction and cell activation (Virts, Barritt et al. 1997). It has been
used as an exclusive marker of the immuno- hematopoietic lineage.

Another cell surface marker, CD34, is a transmembrane cell surface
glycoprotein; it is known to be selectively expressed within the human (Civin, Strauss et
al. 1984; Katz, Tindle et al. 1985) and murine (Baumheter, Singer et al. 1993; Krause, Ito
et al. 1994) hematopoietic systems on stem and progenitor cells. It has been shown to
play a role in adhesion and differentiation control. However, as the cells mature the
expression of CD34 is lost (Wood 1997). Although it is commonly

known as

hematopoietic progenitor antigen it is also expressed on other cells, such as muscle stem
4

cells (see below), vascular endothelial cells (Fina, Molgaard et al. 1990; Baumheter,
Singer et al. 1993) and certain classes of fibroblasts (Suda, Sudo et al. 1992) but it has
been used most widely for enumeration and purification of HSCs.

Skeletal Muscle Stem Cells
Skeletal muscle is subjected to constant injury resulting from weight bearing,
exercise, and trauma. Therefore, muscle requires an ever-available renewable source of
cells for repair and regeneration. Satellite cells, quiescent muscle stem cells, reside
beneath the basal lamina surrounding each myofiber, and are primarily responsible for
postnatal muscle growth and repair (Bischoff and Heintz 1994; Bodine-Fowler 1994;
Cossu and Biressi 2005; Shefer, Van de Mark et al. 2006). When freshly isolated satellite
cells or intact myofibers are transplanted with their associated satellite cells to irradiated
hosts, satellite cells can self-renew, replenish a depleted niche, and their progeny are
capable of efficient regeneration of myofibers (Morgan, Hoffman et al. 1990; Gussoni,
Soneoka et al. 1999; Kamminga, Akkerman et al. 2000; Partridge 2002; Kamminga, van
Os et al. 2005; Fukada, Uezumi et al. 2007). However, satellite cells remain dormant in
mature muscle and only enter the cell cycle in response to injury. The identification of
markers of satellite cells lags behind HSCs, but they do express CD34+ cell surface
marker and the paired-box transcription factor (Pax7). This transcription factor is
specifically expressed in quiescent and newly activated satellite cells and plays a key role
in controlling myogenic differentiation (Grounds and Yablonka-Reuveni 1993;
Yablonka-Reuveni and Rivera 1994; Zammit, Heslop et al. 2002).
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Pax7 is also important for cell survival, having anti-apoptotic functions. The
absence of myogenic satellite cells in young Pax7–/– skeletal muscle demonstrates a
requirement for Pax7 in the function of the satellite cell lineage (Seale, Sabourin et al.
2000; Kuang 2006). Once activated, satellite cells proliferate extensively, and generate a
pool of muscle progenitor cells (MPCs) which subsequently fuse and differentiate. In
cases of minimal muscle damage, MPCs fuse with existing myofibers to repair them,
which can result in hypertrophy upon repeated damage. Upon massive damage, MPCs
fuse with each other to form new myofibers that replace those lost during degeneration.
As the cycle begins and satellite cells are activated, they rapidly initiate expression of the
myogenic regulatory factors (MRFs), MyoD and Myf5, which is accompanied by
downregulation of CD34 and Pax7 (F. P. Moss 2005; Le Grand and Rudnicki 2007; Ueno
and Weissman 2007).

The sequential activation of MRFs and repression of Pax7 is necessary for the
progression of MPCs through myogenic differentiation (Cooper, Tajbakhsh et al. 1999;
Le Grand and Rudnicki 2007). A small fraction of activated satellite cells will exit the
cell cycle and return to the quiescent satellite cell state during muscle regeneration to
maintain their numbers and the regenerative capacity of the muscle (Zammit, Relaix et al.
2006). Activated satellite cells destined to return to the quiescent satellite cell pool have
been putatively identified as cells that lose MyoD or Myf5 expression and maintain Pax7
expression (Megeney, Kablar et al. 1996; McKinnell, Ishibashi et al. 2008). Sca-1 also
shows heterogeneity in expression in activated satellite cells and it has been proposed that
Sca-1 is present on satellite cells that will self-renew as opposed to those that will give
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rise to MPCs (Mitchell, Mills et al. 2005; Fukada, Uezumi et al. 2007; Le Grand and
Rudnicki 2007).

Aging in Stem Cells
Aging has been associated with qualitative and quantitative changes in stem cells.
HSC aging has been linked to a slower and incomplete response to hematopoietic stress,
such that mature blood and immune cells are no longer produced at the same rate at
which they are lost. The age-dependent decline in the activities and/or number of HSCs
has been proposed to contribute to decreased immunity (Linton and Dorshkind 2004),
increased incidence of bone marrow failure (Lichtman and Rowe 2004), hematological
neoplasia (Lichtman and Rowe 2004), and moderate anemia (Beghe, Wilson et al. 2004;
Guralnik, Eisenstaedt et al. 2004), all common effects of aging that occur in humans.
Experimentally, the ability of HSCs to home and engraft the bone marrow is significantly
diminished with age (Lorenzon, Bandi et al. 2004). However, some studies reported that
although HSC function clearly declines with age, the number of HSCs does not
necessarily decline. In some strains of mice, the number of HSC actually expands with
advancing age and this age-dependent expansion of HSCs is a transplantable, cellautonomous property (Morrison, Wright et al. 1997; Mitchell, Mills et al. 2005; Roeder,
Kamminga et al. 2005; Kamminga and de Haan 2006; Chambers, Shaw et al. 2007;
Sharpless and DePinho 2007).
Aging in skeletal muscle is associated with a significant decline in mass, strength,
and endurance in both human and animal models (Cartee 1995; Musaro, McCullagh et al.
1999; Karakelides and Nair 2005). Fewer myofibers are present in aged compared to
young adult muscle and those remaining are atrophied and show increased susceptibility
7

to contraction-induced injury (Edstrom and Ulfhake 2005; Zammit 2006; Zammit, Relaix
et al. 2006). Muscle regeneration is impaired with age and it has been proposed to be the
result of impaired satellite cell function, as well as a decrease in satellite cell number
(Shefer, Van de Mark et al. 2006). Preliminary data from Dr. Peterson’s laboratory
suggest that Sca-1 expression increases in aged MPCs in vivo and in vitro (Hidestrand
2008 in press). This is in contrast to HSCs where Sca-1 deficiency appears to hasten age
associated changes in stem cells (Holmes and Stanford 2007). Therefore the goal of this
project was to characterize Sca-1 expressing cells in muscle as a function of age.

Research Question (Hypothesis)
Sca-1 is a HSC marker that is not expressed in quiescent muscle satellite/stem cells.
However, it is expressed in a subset of MPCs in young adult muscle and it has been
proposed to identify MPCs that will return to the quiescent satellite cell pool. Sca-1
expressing cells appear more abundant in aged muscle but appear to lack myogenic
differentiation capacity. Therefore, I set out to test the hypothesis that Sca-1 marks a
unique population of non-immuno-hematopoietic cells that increases in abundance in
aged muscle that may contribute to impaired muscle regeneration potential during aging.
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CHAPTER 2
Background/Literature Review
Adult Stem Cells
Stem cell research began in the 1960s, when researchers discovered that stem
cells were able to self renew and give rise to one or more progeny (Till and Mc; Becker,
Mc et al. 1963; Siminovitch, McCulloch et al. 1963). This description of adult stem cells
continues to be the definition of choice, even in the 21st century, as current researchers
continue to show that the hallmarks of stem cells are: self-renewal, capacity to maintain
the frequency of stem cells in a given tissue and differentiation to maintain that tissue’s
physiological function (Krtolica 2005). These attributes are found to be important in both
tissue repairs after injury and during the normal process of aging (Lorenzon, Bandi et al.
2004; Rando 2006; Bellantuono and Keith 2007). Scientists have found adult stem cells
in many more tissues than was once thought possible, maintaining regenerative organs,
such as blood, skin, liver, skeletal muscle and intestinal tissue (Wong, Lowes et al. 2007).
This has led scientists to contemplate whether adult stem cells could be the gold standard
for treating many devastating diseases.

Therapeutic Potential of Adult Stem Cells
The therapeutic potential of embryonic stem cells remains limited at this time due
to ethical concerns and the lack of federal funding for research. However, adult stem cell
research is fast becoming center stage in the biomedical field as a potential therapeutic
tool. Therefore understanding the basic biological properties of mammalian stem cells is
of paramount importance. The main driving force for stem cell research is the growing
9

demand for regenerative medicine, which offers hope for the treatment of many
devastating degenerative diseases such as diabetes, Parkinson's disease, and Alzheimer's
disease (McKinney-Freeman 2002; Wong, Lowes et al. 2007). Cell therapy has also been
explored for muscle degenerative diseases such as Duchenne muscular dystrophy (DMD)
and muscle atrophy during aging (sacropenia) (Ivanova, Dimos et al. 2002; Cheng 2008).

Satellite cells and their progeny, known to play a role in muscle growth and
regeneration are the primary cells types used for treating muscular dystrophies (Sebille
2005). From clonal analysis (monitor the progeny of individual cells), it was revealed that
the yield and proliferative capacity of MPCs in DMD was down regulated. From the total
number of MPCs obtained per gram of dystrophic muscle, only approximately 5 % were
normal. This contributes to a large proportion (95%) of the cells that remain to give rise
to clones of cells with altered cell morphology, increased doubling times, and poor
growth potential leading to severely impaired muscle growth. (Pavlath, Thaloor et al.
1998). Normally, satellite cells can fully regenerate chemically destroyed myofibers at
least 12 times in succession in vivo, while human MPCs give rise to an average of 108
progeny in vitro (Blau and Webster 1981). This proliferative potential is not just reserved
for muscle regeneration but is also utilized for muscle growth. A 6-fold increase in
muscle fiber diameter occurs in the first 13 years of human life, which is paralleled by an
increase in the number of nuclei per unit fiber (Brooke and Engel 1969). Similar
increases in the size and nuclear number of muscle fibers accompanies postnatal
development in the mouse (Cardasis and Cooper 1975). Due to the absence of nuclear
division within differentiated multinucleated myofibers, the additional nuclei must be
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exogenous in origin and contributed by the division and fusion of adjacent satellite cells/
MPCs (Stockdale and Holtzer 1961; Blau, Webster et al. 1983).

Presently scientists in many laboratories are trying to find ways to grow adult
stem cells in cell culture and manipulate them to generate specific cell types so they can
be used to treat injury or disease. In the case of neurodegenerative diseases, potential
treatments include replacing the dopamine-producing cells in the brains of Parkinson's
patients (Stredrick, Stokes et al. 2004) and hippocampal neurons in Alzheimer’s patients
(Kelly and Ferreira 2007); for type I diabetes, developing insulin-producing cells
(Zulewski 2007); and for the cardiovascular system, replacing scarred heart muscle
following a heart attack (Dalton 2008). Hematopoietic stem cells (HSCs) are perhaps the
best characterized adult stem cell population and have been used most successfully for
therapeutic purposes (Wilson and Trumpp 2006). HSC transplantation (HSCT) can cure
or treat hematopoietic failures, immune deficiencies, leukemias and certain other cancers
(Cheng 2008). The two major types of HSCT are autologous and allogeneic, which are
defined by the donor graft source. In autologous HSCT, the patients undergo
myeloablative doses of chemotherapy and/or radiation designed to remove all
malignancies from the body. These patients have a malignancy that has either proven to
be resistant to the standard chemotherapy or considered to be high risk for relapse even
though complete remission may have been achieved (Shizuru, Negrin et al. 2005). The
doses given to patients are very high and the bone marrow is ablated in the process.
Therefore the patient must undergo a bone marrow harvest of their own stem cells prior
to treatment and complete their regimen with transplantation. However, only a fraction of
patients are cured using autologous HSCT because in many patients, the disease recurs as
11

the HSCs of patients with leukemia are often contaminated with cancer-initiating cells or
so-called cancer stem cells (see Stem Cell Hierarchy section, below). In 2000, three
separate clinical trials were carried out for patients with multiple myeloma (Michallet,
Philip et al. 2000), non-Hodgkin's lymphoma (Vose, Zhang et al. 2001), and metastatic
breast cancer (Negrin, Atkinson et al. 2000). The goal of the trials was to purify HSCs,
and thereby reduce the burden of occult malignant cells. In all three diseases, harvested
bone marrow (BM) or mobilized peripheral blood (MPB) were known to contain a
significant percentage of contaminated malignant cells. Reports from the studies showed
that purified HSCs resulted in excellent removal of the tumor cells.

Allogeneic HSCT is also used for high risk, relapsed or chemotherapy refractory
malignancies, especially in patients with early hematopoietic progenitor cancer such as
chronic myeloid leukemia (CML) or bone marrow failure states (aplastic anemia). These
patients undergo myeloablative doses of chemotherapy and/or radiation and then are
transplanted with stem cells from an allogenic donor. These are members from the same
species that are genetically different, but are matched at the human leukocyte antigen
(major histocompatibility complex), called H2 in mouse, a complex of genes encoding
cell surface molecules that are required for antigen presentation to T cells and the cause
of graft rejection. The allogeneic HSCT patient is at risk for graft-versus-host-disease
primarily because the transplant is not genetically identical and they contain mature
immune cells that can respond against the host-specific antigens and cause graft- versus
host rejection (Shizuru, Negrin et al. 2005). For both autologous and allogeneic HSCT,
chemotherapy and/or radiation may not eradicate the resident cancer stem cell (see Stem
Cell Hierarchy section below), which renders the diseases essentially incurable. For
12

example, in CML, a well known HSC cancer, Bcr-Abl tyrosine kinase inhibitors have
been used as the first-line treatment (Druker 2002). Although HSCT is successful, CML
can recur after long periods of remission due to reactivation of a dormant cancer stem cell
(Ren and Mu 2005). Bone marrow or mobilized peripheral blood are the most commonly
used sources of HSCs for transplantation in the treatment of leukemia and is most
effective when the leukemia is in remission. However, there is an alternative source of
allogenic HSCs, human umbilical cord blood (UCB). It has been identified to contain a
rich source of primitive HSCs (Gluckman and Locatelli 2000). However, this type of
transplant is especially important for patients unable to match either related or unrelated
donors (Hofmeister, Zhang et al. 2007). It improves donor availability for transplantation
because frozen and stored UCB can be made available on demand. Infectious agents,
such as cytomegalovirus (CMV), are rarely found in the new born compared to adults.
UCB cell transplants have a lower incidence and severity of GVHD than conventional
BMT, allowing successful transplantation in the HLA-mismatched recipient (Mao, Wang
et al. 2004). However, due to the limited sample size which results in low number of
HSCs, it is primarily used for pediatric patients (Hofmeister, Zhang et al. 2007).
Stem cell research has also played a key role in gene therapy, a technique for
correcting defective genes responsible for disease development or delivering a
therapeutic gene product (Bordignon and Roncarolo 2002). Due to their self-renewing
and differentiation properties, HSCs are ideal vehicles for delivery of therapeutic
transgenes for expression in their progeny. Examples of success using combinational
stem cell and gene therapies to treat inherited disorder are: adenosine deaminase in
deficient patients and myoblast therapy for delivery of dystrophin (Payne, Oshima et al.
13

2005; Sebille 2005), the missing gene in DMD. Cellular cardiomyoplasty, a procedure
involving the transplantation of exogenous cells into the heart to regenerate diseased
myocardium, has also been used deliver therapeutic genes, and improve cardiac function
(Bonaros, Rauf et al. 2007). Vascular endothelial growth factor (VEGF) is known to play
a key role in blood vessel formation and the mobilization of stem cells from the bone
marrow. It has been delivered to exert a mitogenic effect on cardio- myocytes (Springer
2002).

Stem Cell Hierarchy
Due to their ability to self renew, adult stem cells are maintained at roughly stable
levels throughout adult life. However, when there is an increased demand for a particular
cell type, stem cells divide and go through a series of specializations such that the initial
pluripotent stem cell gives rise to progeny with differing proliferative capacities and
increasingly restricted potential (Uher 2000). This has been most thoroughly described
for HSCs, where it has been shown that in mice, one HSC can completely restore the
erythroid population and the immune system following irradiation, while in humans, less
than 10% of a donor’s total volume of bone marrow can provide enough HSCs to
completely restore the recipient’s hematopoietic system (Kindt 2007) .
In mice, bone marrow cells are sub- divided into long-term self renewing HSCs
(LT-HSCs), short-term self-renewing HSCs (ST-HSCs) and multipotent progenitors
(MPPs) that lack self- renewal properties. The LT-HSCs give rise to the ST-HSCs, which
give rise to the MPPs (Weissman 2000). Highly purified HSCs can be isolated by FACS
using the cell surface markers c-kit+ Thy-1.1low lineage
14

/low

Sca-1

pos

(Christensen and

Weissman 2001). LT-HSCs fulfill the criteria of HSCs due their ability to give rise to the
lymphoid and myeloid lineages indefinitely after transplantation into lethally irradiated
recipients. ST-HSCs have more limited self-renewal capacity and are capable of giving
rise to these lineages for 8–12 weeks (Zipori and Honigwachs-Sha'anani 1992;
Christensen and Weissman 2001). The MPPs then further sub-divide to form progenitor
cells that become committed to either common myeloid progenitors (CMPs) or common
lymphoid progenitors (CLPs). The myeloid progenitor cells differentiate to form either
granulocyte/macrophage progenitors (GMPs) or erythroid/megakaryotic progenitor cells
(MEPs). The GMPs terminally differentiate to form dendritic cells, granulocytes and
macrophages, while the MEPs terminally differentiate to form erythrocytes and
megakarocytes. Similarly, CLPs differentiate to form dendritic cells, Pro-B progenitors,
Pro-T progenitors and Pro-NK progenitors. These progenitors finally form mature B
cells, T cells and Natural Killer cells, respectively (Morrison, Shah et al. 1997). In young
adult mice, approximately 8% of the LT-HSCs enter cell division per day randomly,
however half their progeny must remain LT-HSCs to maintain the steady state level
(Weissman 2000).

This elaborate hierarchy has important implications for cancer biology. As DNA
replication is prone to error, cell division provides the opportunity for the genome to
suffer mutations, some of which may result in cancer. Stem cells have a long life span
with the ability to survive in severe environments, to stay quiescent in the G0 phase of the
cell cycle most of the time, and to self-renew, making them susceptible to accumulation
of mutations over time potentially leading to formation of a true cancer stem cell (CSC)
(Cheng 2008). However, in the hematopoietic system, keeping the number of LT-HSCs
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low and their frequency of division low, the chance of a catastrophic event leading to
formation of a true CSC is also low (Kindt 2007).

The confinement of rapid proliferation to ST-HSCs and MPPs with limited life
span and limited self-renewal capability, assures that mutations in these cells will likely
not give rise to new cancer. The current stem cell theory of cancer postulates that only
CSCs, not most of the remaining constituent cancer cells, are responsible for
tumorigenesis, progression, and metastasis (Komuro, Saihara et al. 2007). The CSCs can
generate their descendants, including progenitors and relatively differentiated cancer
cells, producing the heterogeneity of the cancer. Further, CSCs survive conventional
anticancer therapies that target only the rapidly dividing cancer cells, whereas their
descendants (most remaining constituent cancer cells) are killed, which may be strongly
related to treatment failure, as well as cancer relapse (Asakura, Seale et al. 2002). It
should also be noted that the key for homeostatic regulation of stem cells depends on the
dynamic niche maintaining a balance between proliferation signals and anti-proliferation
signals. Any genetic mutation that leads stem cells to become independent of growth
signals, or to resist antigrowth signals, will cause the stem cells to undergo uncontrolled
proliferation and possible tumorogenesis. (Diabira and Morandi 2008).

Stem Cell Markers
As introduced in Chapter 1, HSCs and their progeny are characterized by the
array of cell surface antigens that they express. Clonogenic pluripotent mouse HSCs and
progenitor cells are contained within the CD 34neg Sca-1
lineage (Lin)

/low

pos

CD45neg c-kitpos (CD117)

and Thy-1.1low(CD90) population of bone marrow (Ito, Li et al. 2003;
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Abedi, Foster et al. 2007). It is suggested that this population of cells may represent
universal pluripotent stem cells residing at different levels in multiple murine tissue cells
(Grounds and Yablonka-Reuveni 1993). Lineage (Lin) markers are cell surface markers
that mark differentiated peripheral blood cells (e.g. CD4-and CD8-). The marker, c-kit, or
CD117, is another transmembrane glycoprotein and a member of the receptor tyrosine
kinase subclass III family that is expressed on a number of cell types, including HSCs,
mast cells, germ cells, and melanocytes (Wong, Lowes et al. 2007). It is important in the
proliferation and differentiation of hematopoietic cells and is coexpressed on 50–70% of
CD34+, HSCs (Dooley, Oppenlander et al. 2004; Sharma, Cabana et al. 2008). Thy-1
(CD-90) is a rather promiscuous molecule. It is expressed by several different cell types,
and, among others, it is present on the surface of stem cells. It is expressed on 10–40% of
CD34+ cells, the non-expressing population being HSCs (Christensen and Weissman
2001; Wong, Lowes et al. 2007).
Sca-1 in Muscle
In muscle, although 99% of quiescent satellite cells do not express Sca1, it is expressed
in myogenic progenitor cells (MPCs) where it plays a role in regulating proliferation, cell
cycle exit, differentiation, and fusion (Asakura, Seale et al. 2002). Primary MPCs
heterogeneously express Sca-1 and those that are Sca-1

pos

divide slower and form

myotubes less readily than their Sca-1neg counterparts (Mitchell, Mills et al. 2005).
Blocking Sca-1 by antibodies or down regulating expression via antisense, inhibited MPC
fusion and promoted proliferation. Therefore, in the absence of Sca-1, proliferation and
differentiation are favored at the expense of self-renewal. This has led to the proposal
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that Sca-1 expressing MPCs represent “reserve cells” destined to return to quiescence
thereby maintaining the satellite cell pool (Zammit and Beauchamp 2001).

Other populations of cells expressing Sca-1 have been isolated from muscle
tissue, leading to the hypothesis that there exists a more primitive stem cell population in
muscle that gives rise to satellite cells, such that a stem cell hierarchy may also exist in
muscle (Cossu and Biressi 2005). Polesskaya reported that CD45posSca-1

pos

muscle-

derived cells give rise to Pax7pos myogenic cells in response to Wnt signaling during
regeneration. However, this has not been confirmed and it is generally accepted that
CD45 is restricted to immuno-hematopoietic cells and is used to distinguish these cells
from myogenic cells in muscle (Polesskaya, Seale et al. 2003; Sharma, Cabana et al.
2008).
Endothelial cells found in the blood vessels of muscle readily express Sca-1
(Tamaki, Akatsuka et al. 2002). It is possible that they are a source of satellite cells as
endothelial cells from the retina have been shown to activate early satellite cell markers
and undergo myogenic differentiation when transplanted into muscle (Kirillova, Gussoni
et al. 2007). Pericytes (mural cells), another type of cell from the vasculature system, may
replenish the satellite cell pool when satellite cells are depleted during injury or in
neuromuscular degenerative disorders such as DMD (Dellavalle, Sampaolesi et al. 2007).
Pericytes isolated from postnatal human skeletal muscle blood vessels can differentiate
into muscle fibers in vitro and participate in muscle regeneration in vivo in host mice.
The following are characteristics of pericytes compared to satellite cells: (1) they are
located under the endothelium of small vessels, whereas satellite cells are located
underneath the basal lamina of muscle fibers; (2) their growth requirements differ,
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pericyte-derived cells undergo rapid senescence in cell culture media whereas satellite
cells divide; (3) when placed in tissue culture under proliferation conditions, the
pericytes-derived cells, unlike satellite cells do not express Pax7, MyoD or Myf5. Instead
they express NG2 proteoglycan and alkaline phosphatase (ALP), both of which are not
expressed in satellite cells. However, pericytes can undergo myogenic differentiation and
express myogenic markers (MyoD and Myf5) (Dellavalle, Sampaolesi et al. 2007).
Furthermore, pericyte-derived cells can cross the vessel wall, a feature presumed to be
absent in satellite cell-derived myogenic progenitors, which make them potential
candidates for cell therapy via systemic delivery to muscle (see Therapeutic Potential of
Adult Stem Cells section, above) (Day, Shefer et al. 2007).

Aging
The most notable age-associated, functional change in HSCs, is the decreased
ability to home and engraft in the bone marrow (Bordignon and Roncarolo 2002). This is
true in rodents and humans; in a clinical setting increased donor age in bone marrow
transplantation was found to be a predictor of transplant-related mortality. This suggests
that the diminished reconstituting ability of HSCs from elderly donors is partly cellautonomous. These observations further suggest a clinically overt decrease in HSC
functioning with normal human aging (Morrison, Wright et al. 1997). Detailed analysis
of aging effects on HSCs in rodents is complicated by significant differences between
strains. The HSCs of the C57BL/6 (B6) mice are only minimally affected by aging
because their numbers increase with age (de Haan and Van Zant 1999; Chen, Astle et al.
2000; Sudo, Ema et al. 2000) and these cells can outlive their original donor during serial
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transplantation (Harrison 1979). In B6 mice, the homing properties of HSCs are altered,
reducing their ability to engraft recipients (Morrison, Wandycz et al. 1996; Liang, Van
Zant et al. 2005). The progenitor cells from older B6 mice have a relatively low cycling
activity, whereas the stem cell pool increases with age and is relatively small (Kamminga
and de Haan 2006).

Compared to the B6 mice, aged DBA/2 (D2) mice have a shorter life span. An
increased cycling activity is shown by their progenitors and an apparent exhaustion of the
stem cell pool during maturation (de Haan, Nijhof et al. 1997). The stem cell pool of D2
mice decreases upon aging and is relatively large, which suggests that rapidly dividing
cells exhaust faster than progenitor cells. Thus, the maximum life span of different inbred
mouse strains negatively correlates with the percentage of progenitors in the S-phase of
the cell cycle (Roeder, Kamminga et al. 2005). The genetic differences with respect to
cycling activity and stem cell pool population are still present when D2 and B6 cells coexist in the same micro environment, suggesting these are cell intrinsic properties. In
addition, differences between the growth advantage of D2 and B6 stem cell appear to be
dependent on the actual state of the entire system and not a fixed cellular property(De
Haan and Van Zant 1999).

In muscle, the relative roles of the aging environment compared to age-associated
inherent changes in satellite cell function are less clear cut. When young or aged muscle
tissue is transplanted into a young host muscle bed, regeneration is excellent (Brack,
Conboy et al. 2007). The opposite is observed in an aged host, which indicates that a
systemic effect could be occurring. Similarly, when parabiotic pairs of young and aged
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mice sharing a common circulation are injured, the muscles of the aged partner showed
improved regenerative responses when parabiosed with a young mouse, whereas
regeneration in the young animal is impaired (Schultz and Lipton 1982; Dodson and
Allen 1987; Taylor-Jones, McGehee et al. 2002; Barani, Durieux et al. 2003; Gallegly,
Turesky et al. 2004).
Work in vitro suggests that there are also intrinsic changes in MPC function that
contribute to age dependent muscle loss (Lorenzon, Bandi et al. 2004; Conboy, Conboy
et al. 2005; Fulle, Di Donna et al. 2005). Alterations in rodent MPC metabolic activity
and proliferative capacity occur with age. Further, changes in differentiation potential
may contribute to intramyocellular lipid accumulation and muscle fibrosis, both
processes regulated by Notch and Wnt signaling (Kida, Asahina et al. 2007; Brack,
Conboy et al. 2008). The Wnt family of genes, encoding at least nineteen lipid modified
signaling proteins, have been implicated in regulating proliferation and differentiation
through the canonical -catenin and non-canonical pathways (for review see (Huelsken
and Behrens 2002). Changes in Wnt 10b expression with age contribute to increased
adipogenic potential of MPCs and overall Wnt/β catenin signaling increases in muscles
as function of age (Vertino, Taylor-Jones et al. 2005) (Shimizu, Julius et al. 1997;
Willert, Brown et al. 2003; Brack, Conboy et al. 2007).

On the other hand, two recent studies (Shefer, Van de Mark et al. 2006; Collins,
Zammit et al. 2007) show that satellite cell number is reduced with age, but the cells that
remain retain proliferation and differentiation capacity. An age-dependent loss in cells
destined for self-renewal from the satellite cell/MPC population would result in reduced
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regenerative capacity. Based on this work, Dr. Peterson’s lab set out to test the hypothesis
that Sca-1 expressing MPCs may be absent or depleted in aged muscle following injury.
Immunohistochemical analysis of aged muscles suggested that Sca-1 expressing cells
were actually increased in muscle with age and these cells appeared to lack myogenic
potential (Hidestrand 2008 in press). The goal of my study was to quantify Sca-1
expressing cells in muscle as a function of age and characterize them in vitro.
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CHAPTER 3

Experimental Materials and Methodology
Animals

Six months old (young adult) and 23-24 months old (aged) female DBA/2JNIA
mice were obtained from the National Institute of Aging (NIA) Aged Rodent Colony at
Harlan Sprague Dawley (Indianapolis, IN) and housed in the animal facility at the
University of Kentucky (UK) with access to food and water. They were maintained on
normal chow. All studies were approved by the University Animal Care and Use
Committee and overseen by the Division of Laboratory Animal Resources (DLAR) at the
University of Kentucky.

Muscle – Derived Cell Isolation

Cells were isolated from muscles of both hind limbs of 6 young adult and 6 aged
DBA/2JNIA mice by enzymatic digestion. Bones and tendons were removed, and the
muscle tissue was thoroughly minced and then centrifuged for 2 minutes at a speed of
800 x g and resuspended in DMEM (Dulbecco’s modified Eagle medium) (Invitrogen,
Carlsbad, CA) with penicillin and streptomycin (p/s) (Invitrogen). The muscle was then
digested for 30 minutes at 37°C in 5% CO2 with 0.2% collagenase type II-filtered
(Boehringer, Mannheim, Germany) which breaks down the native collagen to release
cells, followed by 30 minutes in 0.5μ/mL of Dispase (Boehringer, Mannheim, Germany)
a protease that is milder compared to collagenase. Following digestion, the cells were
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pelleted by centrifugation for 3 minutes at 1000x g and resuspended in 10 ml of DMEM
with 10 % fetal bovine serum (FBS, BioWhittaker, Walkerville, MD). The dissociated
tissue was triturated briefly by using a 25-mL pipette and was then passed sequentially
through 70-µm and 40 µm nylon mesh filters. Cells were counted manually using a
hemocytometer (see detailed description below), which typically yielded 3 × 106 to
4 × 106 cells/mouse before the filtrate was incubated at 37 OC in 5% CO2 for 6 hours.
Cells were then centrifuged for 5 minutes at 900xg and resuspended in 1 ml of phosphate
buffered saline (PBS).

Cell Counting
The hemacytometer counting chamber was used for counting cells on the inverted
microscope at 10x and 40 x powers. It is constructed so that the distance between the
bottom of the cover slip and the surface of the counting area of the chamber is 0.1mm.
The surface of the chamber contains two square ruled areas separated by an H-shaped
moat. These two squares are identical allowing the counter to duplicate the cell count.
Approximately 20μL of the total cells obtained in the above experiment was diluted in
media (1:50 dilution). In a new tube 20μL of the dilution was added to 20μL of trypan
blue (discussion below). Approximately 10μL of the solution was placed on the
hemactyometer covered by a coverslip and counted using at least two quadrants. The
following calculation below was used to determine the total amount of cells.

Grp1: (______/2) * 100 * (10,000) = _______ cells/mL*___mL =

*multipy

All subsequent steps were performed on ice at 4 OC. Cells were counted for a
second time using trypan blue. In a viable cell, trypan blue is excluded; however, it
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traverses the membrane in a dead cell. Hence, dead cells are shown with a distinctive
blue color under a microscope. The remaining cells were centrifugated for 5 minutes at
600 x g and then resuspended in 100uL viral supernatant 2.4G2 (HB197, ATCC,
Manassas, VA) at a concentration of 5x106 cells/mL and incubated for 15 minutes in
order to block nonspecific binding of the CD45 antibody. After incubation the cells
were centrifuged for 5 minutes at 600 x g and resuspended in 3mL of PF buffer (PBS
with 0.5% FBS).
Antibody Labeling

The primary antibodies of CD45.2 conjugated with Allophycocyanin (APC)Alexa® Fluor750 and Sca-1, Ly-6A/E conjugated with Phycoerythrin (PE) were prepared
and aliquoted in the following tubes:
1. Control Tube 1 : 75 µL of PF media only
2. Control Tube 2: 75 µL of PF and 15 µL of CD45: APC: AF (1:5 )
3. Control Tube 3: 75 µL of PF and 0.5µl Sca-1: PE(1:160)
4. Sample Tube: 500µL of PF including 100µL CD45: APC-AF (1:5) and 3.125
µLSca-1: PE (1:160). The cells sample volume aliquot for all controls was
determined by the following standard calculation :
(0.5 X106) * (total volume/total cell count) (* multiply).

Antibody CD45.2 is commonly used for the following mouse strains C57BL/6, BALB/c,
DBA/1, and DBA/2. It is a 104 clone monoclonal antibody, which reacts with the mouse
CD45 molecule. The conjugation with the fluorescent dye (APC)-Alexa® Fluor 750
produces photo-emission properties and compensation, which includes the peak emission
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of 779 nm, a slightly higher mean fluorescent intensity and a more photo stable
fluorochrome when compared to the similar clone conjugated antibodies. The Sca-1Ly6A/E antibody is also commonly used in similar mouse strains previously listed above. It
is a monoclonal antibody that reacts with both Sca-1Ly-6A.2 and Ly-6E.1 molecules. The
conjugation of Sca-1Ly-6A/E antibody with phycoerythrin (PE), one of the most
commonly-used fluorescent dyes for FACS analysis (see detailed discussion below)
produces a huge absorption coefficient and almost perfect quantum efficiency. It emits at
about 570 nm, one of the brightest dyes used today. However, it is sensitive to photoinduced oxidation; therefore, the dye and samples containing the dye must always be
protected from light.
In order to determine the final volume of cells to be used for FACS analysis, a
final count was done (the number of cells must be ≥

1.0x107mL), which yielded

approximately 1.2x107 and 2.1x107 cells for the aged for the adult mice respectively.
Cells were added to the four tubes described above and centrifuged for 4 minutes at 600
x g and resuspended in 0.5mL of PF buffer (process was repeated twice). Eppendorf
collection tubes were prepared to collect samples after they were sorted. Immediately
before the samples were subjected to FACS, a 1:3 dilution of propidium iodine (PI) in
PBS was made and added to the tube. PI is commonly used for identifying dead cells in a
population of cells and also acts as a counter stain in multicolor fluorescent techniques.
Finally, due to the viscosity of the labeled cells, they are filtered through a 30 µm filter
and then approximately 2-4 mL were subjected to FACS analysis on a BD Biosciences
FACS Vantage cell sorter. The aim was to collect Sca-1 positive and negative cells
isolated

from

the

CD45

negative

pool,
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which

were

then

cultured

for

immunocytochemistry and/or for RNA isolation. The entire FACS analysis was repeated
on both groups of 6 young adult and 6 aged mice twice.
Flow Cytometry for FACS Analysis
Since its inception more than 30 years ago flow cytometry has become an
essential tool for both researchers and clinicians. This technique is used for counting,
examining, and sorting microscopic particles suspended in a stream of fluid (Longobardi
2001). It allows simultaneous multiparametric analysis of the physical and/or chemical
characteristics of single cells flowing through an optical and/or electronic detection
apparatus. A flow cytometer is similar to a microscope, except that instead of producing
an image of the cell, flow cytometry offers high-throughput (for a large number of cells)
automated quantification of set parameters (Shapiro 2003). Fluorescence-activated cell
sorting/sorter (FACS) is a specialized type of flow cytometry. It provides a method for
sorting a heterogeneous mixture of biological cells into two or more containers, one cell
at a time, based upon the specific light scattering and fluorescent characteristics of each
cell. It provides fast, objective and quantitative recording of fluorescent signals from
individual cells as well as physical separation of cells of particular interest (Longobardi
2001).As the fluid containing the cells, which is entrained in the center, passes through a
narrow orifice (~100µm in diameter) into the air, a beam of light (usually laser light) of a
specific wavelength is directed onto this hydro-dynamically focused stream of fluid
(Wiley-Liss 2007). At the same time, the flow chamber is vibrated by the attached
piezoelectric crystal, at frequencies approximating 20,000Hz. The vibration produces a
disturbance in the ejected stream. The disturbance grows very rapidly and the stream
eventually breaks into individual droplets (20,000 drops per second)(Wiley-Liss 2007).
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The steady vibration causes the drops to be uniform in size and spacing. Each cell that
flows through the system will end up in a drop. A number of detectors are aimed at the
point where the stream passes through the laser light beam; one in line or approximately
20-200 with the light beam (Forward Scatter or FSC), several perpendicular or 900 to it
(Side Scatter or SSC) and one or more fluorescent detectors (Shapiro 2003).
Each suspended particle passing through the beam scatters the light in some way,
and fluorescent chemicals found in the particle or attached to the particle may be excited
into emitting light at a lower frequency than the light source. This combination of
scattered and fluorescent light is picked up by the detectors, and by analyzing fluctuations
in brightness at each detector (one for each fluorescent emission peak) it is then possible
to extrapolate various types of information about physical and chemical structure of each
individual particle. FSC correlates with the cell volume and size of the cell. It is also
more sensitive to surface properties of particles (cell ruffling) and will distinguish live
from dead cells. SSC depends on the inner complexity of the particle (i.e. shape of the
nucleus, the amount and type of cytoplasmic granules or the membrane roughness)
(Wiley-Liss 2007).
Finally, if the measurement result indicates that the cell is to be sorted, a voltage
is applied to the stream and a droplet begins to form. When the drop separates from the
stream it will carry an electric charge. The voltage on the stream is immediately reduced
to zero so that other drops will not be charged. Charges can be negative or positive,
enabling the sorting of two categories of cells simultaneously. As the drop continues to
move downward, they pass between two metal plates charged to a high voltage. The
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drops now contain the selected charged cells and because of this they are deflected from
the main stream of drops and collected in eppendorf tubes for visual examination or
cultured for RNA isolation. Drops containing undesired cells are not charged and go
directly into a waste tube (Shapiro 2003).
RNA Isolation
Following FACS, Sca-1 labeled (Sca-1pos) and unlabeled (Sca-1neg) cells from the
CD45 negative population were expanded on collagen-coated plates (Sigma, St. Louis,
MO) and maintained in growth medium containing Ham’s F-10 (BioWhittaker)
supplemented with 20% FBS, 0.5% pen-strep and 5 ng/mL basic fibroblast growth factor
(bFGF, Promega, Madison, WI) at 37 C in a humidified 5% CO2-95% air atmosphere.
To assess myogenic potential, cells were grown to confluence and then switched to
differentiation medium consisting of DMEM with 2% horse serum (Hyclone, Logan, UT)
and 0.5% pen-strep. Total RNA was prepared from primary cultures using the RNAqeous
4PCR kit (Ambion, Austin, TX) including DNAse treatment technique, according to the
manufacturer’s recommendations.

This kit disrupts cells in a solution containing

guanidinium thiocyanate (lysis binding solution), a strong chaotropic denaturant which
lyses cell membranes and rapidly inactivates cellular ribonucleases (Chirgwin, Przybyla
et al. 1979; Chomczynski and Sacchi 1987). Approximately 105 cells were disrupted by
the addition of lysis binding solution and then transferred to a tube and vortexed to ensure
complete cellular disruption. The lysate was then mixed with an ethanol solution, and
applied to a silica-based filter which selectively binds mRNA and the larger ribosomal
RNAs; however, very small RNAs such as tRNA and 5S ribosomal RNA are not bound.
The filter was washed to remove residual DNA, protein, and other contaminants, and the
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RNA was eluted in nuclease-free water containing a trace amount of EDTA to chelate
heavy metals. The silica filter is housed in a small cartridge which fits into the RNasefree microfuge tubes supplied with the kit. The sample lysate, wash solutions, and elution
solution are permeated through the filter by centrifugation or vacuum pressure. The entire
RNA isolation procedure takes about 10 minutes. After elution from the filter, the RNA
was treated with the ultra-pure DNase 1 solution provided with the kit by the manufacture
to remove trace amounts of DNA. Finally, the DNase was inactivated and divalent
cations removed. DNase treatment and inactivation takes about 30 minutes. This
treatment is critical in the RT-PCR technique because no RNA isolation procedure can
guarantee the complete removal of trace amounts of DNA below the limit of detection by
RT-PCR. It is especially important that no DNA is present in RT-PCRs using primers
that do not flank introns, or for genes that have processed pseudogenes, because the RTPCR products from RNA and contaminating DNA cannot be distinguished by size in
these cases. The DNase I solution was removed because it could degrade DNA made in
the PCR. The DNase Inactivation Reagent is also used to remove divalent cations
introduced by the DNase 1 Buffer. The quality of RNA was assessed with a Bioanalyzer
nanochip assay (Agilent Technologies, Santa Clara, CA) and RNA concentration was
determined with a spectrophotometer by measuring the absorbance at 260 nm.
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Real time Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
RNA was analyzed using RT-PCR, the most sensitive technique for mRNA
quantification that is routinely used. The technique is sensitive enough to enable
quantitation of RNA from a single cell. Gene expression was quantified by real-time RTPCR utilizing a standard curve from pooled cDNAs on an IQ5 icycler using SYBRGreen
(BioRad, Hercules, CA). For these experiments 1 µg of RNA was converted to cDNA
using the iScript reverse transcriptase kit (BioRad). Depending on the gene being
analyzed 0.1-10 ng of cDNA/well was used for real-time analysis. In all cases the primer
concentrations were held at 0.3µM and the annealing temperature was set at 60°C.
Reactions were characterized by a single peak melting curve, 90-110% amplification
efficiency of the standard curve, and no amplification of a non- template control. Samples
were run in duplicate and experiments repeated 3 times. Each value was normalized to
18s ribosomal RNA using 18s F primer 5'- AATGAGCCATTCGCAGTTTC -3' and R
primer 5'- CTCTGTTCCGCCTAGTCCTG -3'. All other primer sequences can be found
at http://pga.mgh.harvard.edu/primerbank/ using the following Genbank accession
numbers: Cyclin D1, NM_007631; CyclinD2, NM_009829; Myc, NM_010849; Wnt2,
NM_023653; Wnt7b, NM_009528; Wnt10, NM_011718; Twist1, NM_011658;
Fibronectin, AF095690; CTGF, NM_010217. Results were analyzed using two–way
Analysis of Variance (ANOVA) and are presented as means and standard deviations.
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CHAPTER 4
Results

Quantification of Sca-1 expressing (Sca-1 pos) cells from adult and aged mice muscle
Immunohistochemical analysis of mice hind limb muscles showed that Sca-1
expressing cells increased in abundance with age(Hidestrand 2008 in press). To quantify
the cells and characterize them in detail, hind limb muscles of adult (6 months old n= 6)
and aged (23-24 months old, n= 6) female mice were enzymatically digested and
mononucleated cells isolated. The muscle derived cells were counted (three times) at
different stages throughout the experiment manually with a hemocytometer prior to
Fluorescent Activating Cell Sorting (FACS). Table 1 show that muscles from the adult
mice yielded a larger number (43.5 x106) of cells overall compared to the aged muscles
(23x106). However, significant cell loss was noted in both age groups during further
processing such that cell number dropped by approximately half (11.5 x106 cells from
aged mice and 21.0 x106 cells from adult). Finally, the cells yielded by both groups of
mice are consistent with published data, which suggest that a typical yield of cells for two
hind limbs from a mouse ranged between 3 x107- 4x107.

Table 1: Summary of cells counted manually by hemocytometer prior to FACS Analysis
Type of mice

Count 1

Count 2

Count 3

Aged

2.3 x107

1.2 x107

1.2 x107

Adult

4.4x107

2.2 x107

2.2 x107
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Figure1A.

Figure1B.

Figure1C.
Figure1: Fluorescent Activating Cell Sorting (FACS) parameters for CD45neg cells.
The above figures illustrate a profile of all cells to be sorted based on size (FSC) and
granularity (SSC) (A). The viable cell population (Region 1 in B) enriched for nonhematopoietic stem cells (CD45 negative, R5 in C) was selected using propidium iodine.
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To identify Sca-1

pos

cells derived specifically from muscle progenitors cells (MPCs), an

antibody to CD45 was used to select against immuno-hematopoietic cells (CD45pos).
Several other cell parameters were also quantified during sorting (Figure 1). The forward
scatter (FSC)on the x axis versus the side scatter (SSC) on the y axis in Figure 1A
displays the profile for all cells collected based on their surface properties which includes
size and granularity respectively. In Figure 1B the forward scatter versus propidium
iodine (PI) allows for selection of viable cells (R1) excluding fragments (located on the
far left), aggregates (located on far right) and nonviable cells (PI

pos

). Finally, the

histogram shown in Figure 1C is a representation of the CD45 negative cell population
(R5) that was further sorted based on Sca-1 cell surface expression.
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Figure 2A

FF

F

Figure 2B
Figure 2: FACS profile of CD45 and Sca-1 expressing and non-expressing cells in
muscle from adult and aged mice
CD45 versus Sca-1 cells demonstrates an increased abundance of CD45negSca-1pos cells
in muscle from aged (A) compared to adult (B) mice.

35

Sorting gates of the viable cells (R1, Figure 1B) were used to identify CD45neg Sca-1pos
cells from adult and aged mice. In this representative analysis, repeated twice, 14.2% of
the cells from aged mice were CD45neg and Sca-1pos (Figure 2A), while 7.2% of similar
cells were observed in the adult mice ((Figure 2B). These results show that although total
cell number decreases as a function of age, Sca-1expressing non-immuno-hematopoietic
cells are twice as abundant in aged compared to young adult muscle.
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Figure 3A

Figure 3B
Figure 3: In vitro characterization of Sca-1 pos and Sca-1 neg cells from aged and
young adult muscle in culture.
Sca-1 pos (A) and Sca-1 neg (3B) cells from aged muscle in culture for approximately 2
weeks.
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Previous results from Dr. Peterson’s laboratory showed that although Sca-1 expressing
cells in aged muscle were derived from MPCs, they lacked myogenic potential. Sca-1 pos
cells from aged muscle did not express myogenic genes such as MyoD, and did not fuse
or differentiate into myotubes (Hidestrand 2008 in press).To further characterize

the

Sca-1 expressing cells from aged muscle, the FACS isolated Sca-1pos and Sca-1 neg cells,
were expanded in culture. After approximately two weeks in culture, Sca-1pos cells were
quite large and flattened (Figure 3A) compared to Sca-1

neg

cells (Figure 3B). The

morphology of the Sca-1 neg cells was typical of normal MPCs. They readily differentiate
in low serum- containing differentiation media; whereas the FACS sorted Sca-1pos cells
did not fuse to form myotubes.
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Figure 4: Gene expression analysis of Sca-1 pos cells compared to Sca-1 neg MPCs from
adult and aged muscle.
mRNA abundance for the indicated genes was quantified by real time RT-PCR. The data
were analyzed by two-way Analysis of Variance (ANOVA) and expressed as different
from aged mice (p<0.05 is as * and p<0.005 is assigned as **).
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Sca-1+

To characterize the cells further, RNA was isolated from Sca-1

neg

adult (6

months-old) and aged (23-24 months-old) MPCs and from FACS isolated CD45neg Sca1pos cells from 23-24 months-old mice (stable populations of Sca-1pos cells from young
animals were not available due to the dynamic expression of Sca-1 in these cells) and
analyzed by real time reverse transcriptase PCR (Figure 4). The data presented in Figure
4 represent the means and standard deviations normalized to 18s, expressed as arbitrary
units (AU). The following specific Wnt genes (Wnt2, 7b and 10b,) showed the greatest
difference in gene expression between the cell types. Wnt2 (Figure 4A) was dramatically
over expressed in Sca-1pos cells which was associated with over expression of
downstream target genes of canonical Wnt signaling such as c-myc (Figure 4B) and
cyclins D1 and D2 (Figure 4E and 4H, respectively). Wnt7b mRNA (Figure 4D) was
expressed at lower levels in both cell types from aged mice relative to young adult MPCs,
potentially contributing to decrease myogenic potential in both cell types from aged mice.
The Wnt10b gene (Figure 4G), that has been implicated in regulating adipogenesis was
down regulated only in aged MPCs. Genes involved in fibrosis such as Twist (Figure
4C) connective tissue growth factor (CTGF, Figure 4F) and fibronectin (Figure 4I) were
significantly over expressed in Sca-1pos cells compared to MPCs.
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CHAPTER 5

Discussion and Conclusion
Stem cell antigen-1(Sca-1) is expressed by stem, progenitor, and differentiated
cell types in a wide variety of tissues and organs (Bamezai 2004; Holmes and Stanford
2007). In muscle, it has been proposed to play a role in controlling normal muscle
satellite cell/MPC function (Fukada, Uezumi et al. 2007). However, these experiments
have identified a subpopulation of cells (CD45negSca-1pos) that increase in abundance
with age (Figure 2). This unique subpopulation of cells has an altered differentiation
potential.
Quiescent satellite cells in young muscle do not express Sca-1 and give rise to
MPCs that are heterogeneous for Sca-1 expression (Asakura, Seale et al. 2002). It has
been proposed that Sca-1 may identify MPCs destined to return to the satellite cell pool
(Mitchell, Mills et al. 2005). In aged muscle, cells expressing Sca-1 do not possess
myogenic potential and may be undergoing apoptosis resulting in depletion of the stem
cell pool in vivo (Hidestrand 2008 in press).However, not all cells are lost, and those that
remain do not express myogenic markers and instead may contribute to muscle fibrosis
with age, potentially controlled by Wnt signaling with β catenin as the integral
component of the system (Willert, Brown et al. 2003; Brack, Conboy et al. 2007). Wnts
are a major class of secreted morphogenic ligands with a role in generation, maintenance
and /or differentiation of early progenitor cells in all multicellular organisms (Huelsken
and Behrens 2002). They play a very important role in regulating ostegenesis,
adipogenesis and myogenesis in adult tissues, subsequently controlling the fate of the
resident stem cells (Lako, Lindsay et al. 2001; Vertino, Taylor-Jones et al. 2005). In the
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absence of Wnt signaling, β-catenin is phosphorylated by glycogen synthase kinase
(GSK), leading to rapid degradation. The ligands of Wnt bind to transmembrane receptors
of the Frizzled family, leading to inactivation of GSK within the complex, thereby
stabilizing β-catenin, allowing translocation to the nucleus where it regulates T-cell factor
/leukocyte enhancing factor-dependent (TCF/LEF) gene transcription(Willert and Nusse
1998). Recent studies have shown that Wnts have distinct effects during limb myogenic
differentiation (Van Den Berg, Sharma et al. 1998; Lako, Lindsay et al. 2001; Fevr,
Robine et al. 2007). However, in contrast, Wnt signaling seems to inhibit adipogenic
differentiation (Shimizu, Julius et al. 1997; Ross, Hemati et al. 2000; Bennett, Ross et al.
2002; Vertino, Taylor-Jones et al. 2005; Brack, Conboy et al. 2007; Fevr, Robine et al.
2007).
Due to these important roles of the Wnt signaling pathway it prompted us to
examine this class of genes in Sca-1poscells. In our study, we found that Wnt7b, which
promotes myogenic differentiation (Vertino, Taylor-Jones et al. 2005), is down regulated
in both aged Sca-1neg and Sca-1pos cells, which may contribute to impaired myogenic
potential of both cell populations.Wnt10b, which inhibits adipogenic differentiation
(Ross, Hemati et al. 2000; Bennett, Ross et al. 2002), declines only in aged MPCs,
potentially accounting for increased adipogenic potential specifically in those cells. As
overall markers of Wnt/β-catenin signaling, myc and cylins D1 and D2 appear to be upregulated in the Sca-1pos cells, Wnt7b and 10b likely signal through non-canonical
pathways to control differentiation potential.
Wnt2 (Figure 4A) was highly over expressed in Sca-1pos cells that may be
responsible for increased expression of the down stream targets of canonical Wnt/β42

catenin signaling (Brack, Conboy et al. 2007). Moreover, genes associated with fibrosis,
including Twist1 (Figure 4C), CTGF (Figure 4F), and fibronectin (Figure 4I) are over
expressed in Sca-1pos cells compared to both young adult and aged Sca-1neg MPCs. In the
kidney Wnt 2 is associated with fibrosis and directly regulates Twist 1 gene expression
(Kida, Asahina et al. 2007).Twist also inhibits MyoD function which contributes to
impaired myogenic potential (Hamamori, Wu et al. 1997). These results are consistent
with a recent study done by Brack et. al which also shows that following injury in aged
muscle, satellite cells/MPCs may contribute to fibrosis which is associated with increased
canonical Wnt signaling. The data obtained from our experiments suggest that Sca-1 is a
useful marker of this transition from myogenic to fibrogenic potential during
aging.(Brack, Conboy et al. 2007). The fact that age-dependent differences in phenotype
are stable in culture suggests that inherent changes in cell potential occur. However,
satellite cell and MPC function are also clearly influenced by the aged muscle
environment(Carlson and Faulkner 1989; Conboy, Conboy et al. 2003; Conboy, Conboy
et al. 2005; Rando 2006).

The majority of the work presented and discussed in this paper is on mice;
however, interesting parallels appears to exist with humans muscle progenitor cells.
Presently, a human homolog is not yet identified, however, researchers analyzing Sca-1
mutant mice have demonstrated the following important stem cell concepts that are
equally relevant to human health and disease: the importance of mesenchymal stem and
progenitor cells to bone homeostasis and deterioration, the association between
degenerative diseases and exhaustion of the stem cell pool, and the importance of the
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stem cell stress responses to tissue maintenance (Holmes and Stanford 2007). Therefore,
further experiments are required to determine if modulation of Sca-1 expression may alter
the properties of the satellite cells/MPCs and lead to long-term consequences for muscle
growth.

Finally, due to the growing demand for regenerative medicine, understanding the
basic biological properties of mammalian stem cells, including Sca-1 is of paramount
importance. This could offer hope for the treatment of many devastating degenerative
diseases such as diabetes, Parkinson's disease, and Alzheimer's disease and muscular
degenerative diseases such as Duchenne muscular dystrophy (DMD) and muscle atrophy
during aging (sacropenia).
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